Clinical responses to odronextamab (regn1979): correlation with loss of cd20 expression as a potential mechanism of resistance and baseline biomarkers of tumor t cells
J Brouwer‐Visser,N Fiaschi,R. P Deering,A Dhanik,K. J Cygan,W Zhang,S Jeong,S Pourpe,L Boucher,S Hamon,M. S Topp,R Bannerji,J Duell,R. H Advani,D. M Flink,A Chaudhry,A Sirulnik,I Lowy,A. J Murphy,D. M Weinreich,G. D Yancopoulos,G Thurston,S. R Ambati,V Jankovic
